GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaxis Pharmaceutical Corp (OTCPK:CURXQ) » Definitions » Interest Expense

Curaxis Pharmaceutical (Curaxis Pharmaceutical) Interest Expense : $-0.26 Mil (TTM As of Dec. 2011)


View and export this data going back to . Start your Free Trial

What is Curaxis Pharmaceutical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Curaxis Pharmaceutical's interest expense for the six months ended in Dec. 2011 was $ -0.26 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2011 was $-0.26 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Curaxis Pharmaceutical's Operating Income for the six months ended in Dec. 2011 was $ -1.92 Mil. Curaxis Pharmaceutical's Interest Expense for the six months ended in Dec. 2011 was $ -0.26 Mil. Curaxis Pharmaceutical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curaxis Pharmaceutical Interest Expense Historical Data

The historical data trend for Curaxis Pharmaceutical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curaxis Pharmaceutical Interest Expense Chart

Curaxis Pharmaceutical Annual Data
Trend Dec08 Dec09 Dec10 Dec11
Interest Expense
- -0.37 -2.76 -0.26

Curaxis Pharmaceutical Semi-Annual Data
Dec08 Dec09 Dec10 Dec11
Interest Expense - -0.37 -2.76 -0.26

Curaxis Pharmaceutical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Expense for the trailing twelve months (TTM) ended in Dec. 2011 was $-0.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curaxis Pharmaceutical  (OTCPK:CURXQ) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curaxis Pharmaceutical's Interest Expense for the six months ended in Dec. 2011 was $-0.26 Mil. Its Operating Income for the six months ended in Dec. 2011 was $-1.92 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2011 was $0.00 Mil.

Curaxis Pharmaceutical's Interest Coverage for the quarter that ended in Dec. 2011 is calculated as

Curaxis Pharmaceutical did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Curaxis Pharmaceutical (Curaxis Pharmaceutical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaxis Pharmaceutical Corp (OTCPK:CURXQ) » Definitions » Interest Expense
Comparable Companies
ENZB INBP BSPM ATHJF CPHI INNV ALQA NVGN AXN CHEXD IMNP TNXP PRPH OASM PXSLY NNVC ALIM CKDXF NBRV ZGNX
Traded in Other Exchanges
N/A
Address
Website
http://www.curaxispharma.com
Curaxis Pharmaceutical Corp was incorporated in Delaware on February 27, 2001. It is a specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease. The Company's therapeutic platform is based on the hypothesis that diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that controls development, reproduction and aging in animals. This drug development platform is built on the premise that hormones associated with this feedback loop are beneficial early in life, when they promote growth and development, but are harmful later in life when the mechanism for feedback is compromised, thereby leading to disease processes, including pathologies associated with Alzheimer's disease and various cancers. Its discovery of similar hormonal signaling mechanisms at the cellular level in brain tissue from Alzheimer's patients and in multiple tumors will enable it to develop significant new treatments for Alzheimer's disease and may have applications for many cancers.
Executives
Timothy R Wright director, officer: Chief Executive Officer C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614
Michael W George director C/O CURAXIS, 1004 CHAGFORD WAY, RALEIGH NC 27614

Curaxis Pharmaceutical (Curaxis Pharmaceutical) Headlines

No Headlines